| scholarly article | Q13442814 |
| P50 | author | John Q. Trojanowski | Q6253636 |
| P2093 | author name string | M. Goedert | |
| I. Lieberburg | |||
| G. V. Johnson | |||
| R. Jakes | |||
| R. Barbour | |||
| D. Schenk | |||
| J. M. Litersky | |||
| P. Seubert | |||
| M. Mawal-Dewan | |||
| P2860 | cites work | The carboxyl third of tau is tightly bound to paired helical filaments. | Q53186869 |
| Monoclonal antibody PHF-1 recognizes tau protein phosphorylated at serine residues 396 and 404. | Q53199978 | ||
| Proline-directed and non-proline-directed phosphorylation of PHF-tau. | Q53203171 | ||
| A68: a major subunit of paired helical filaments and derivatized forms of normal Tau. | Q53296439 | ||
| Monoclonal antibody AT8 recognises tau protein phosphorylated at both serine 202 and threonine 205. | Q54613756 | ||
| p42 map kinase phosphorylation sites in microtubule-associated protein tau are dephosphorylated by protein phosphatase 2A1Implications for Alzheimer's disease | Q55920639 | ||
| Abnormal Alzheimer-like phosphorylation of tau-protein by cyclin-dependent kinases cdk2 and cdk5 | Q60603655 | ||
| Tau in paired helical filaments is functionally distinct from fetal tau: assembly incompetence of paired helical filament-tau | Q72901527 | ||
| A protein factor essential for microtubule assembly | Q22010837 | ||
| Cloning and sequencing of the cDNA encoding a core protein of the paired helical filament of Alzheimer disease: identification as the microtubule-associated protein tau | Q24648590 | ||
| Continuous cultures of fused cells secreting antibody of predefined specificity | Q26776979 | ||
| Measurement of protein using bicinchoninic acid | Q26778491 | ||
| Multiple isoforms of human microtubule-associated protein tau: sequences and localization in neurofibrillary tangles of Alzheimer's disease | Q28910345 | ||
| Isolation of a fragment of tau derived from the core of the paired helical filament of Alzheimer disease | Q33582860 | ||
| Biopsy-derived adult human brain tau is phosphorylated at many of the same sites as Alzheimer's disease paired helical filament tau. | Q34324670 | ||
| A cdc2-related kinase PSSALRE/cdk5 is homologous with the 30 kDa subunit of tau protein kinase II, a proline-directed protein kinase associated with microtubule | Q34345777 | ||
| Tau protein function in living cells | Q36216609 | ||
| The abnormal phosphorylation of tau protein at Ser-202 in Alzheimer disease recapitulates phosphorylation during development | Q36335067 | ||
| Alzheimer-like paired helical filaments and antiparallel dimers formed from microtubule-associated protein tau in vitro | Q36531639 | ||
| Tau protein and the neurofibrillary pathology of Alzheimer's disease | Q40386025 | ||
| Altered tau and neurofilament proteins in neuro-degenerative diseases: diagnostic implications for Alzheimer's disease and Lewy body dementias | Q40794805 | ||
| Phosphorylation of microtubule-associated protein tau: identification of the site for Ca2(+)-calmodulin dependent kinase and relationship with tau phosphorylation in Alzheimer tangles. | Q41229492 | ||
| Expression of multiple tau isoforms and microtubule bundle formation in fibroblasts transfected with a single tau cDNA. | Q41585811 | ||
| Epitope mapping of monoclonal antibodies to the paired helical filaments of Alzheimer's disease: identification of phosphorylation sites in tau protein | Q42827866 | ||
| The microtubule binding repeats of tau protein assemble into filaments like those found in Alzheimer's disease | Q43423232 | ||
| Distribution of tau proteins in the normal human central and peripheral nervous system | Q44921131 | ||
| Phosphorylation of Ser262 strongly reduces binding of tau to microtubules: distinction between PHF-like immunoreactivity and microtubule binding. | Q48253590 | ||
| Abnormal tau phosphorylation at Ser396 in Alzheimer's disease recapitulates development and contributes to reduced microtubule binding | Q48277664 | ||
| Glycogen synthase kinase-3 and the Alzheimer-like state of microtubule-associated protein tau. | Q48394153 | ||
| Glycogen synthase kinase-3 induces Alzheimer's disease-like phosphorylation of tau: generation of paired helical filament epitopes and neuronal localisation of the kinase | Q48406074 | ||
| Implication of brain cdc2 and MAP2 kinases in the phosphorylation of tau protein in Alzheimer's disease | Q48444661 | ||
| Tau proteins of Alzheimer paired helical filaments: abnormal phosphorylation of all six brain isoforms | Q48571996 | ||
| Epitopes that span the tau molecule are shared with paired helical filaments. | Q53186865 | ||
| P433 | issue | 32 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | phosphorylation | Q242736 |
| P1104 | number of pages | 6 | |
| P304 | page(s) | 18917-18922 | |
| P577 | publication date | 1995-08-01 | |
| 1995-08-11 | |||
| P1433 | published in | Journal of Biological Chemistry | Q867727 |
| P1476 | title | Detection of Phosphorylated Ser262 in Fetal Tau, Adult Tau, and Paired Helical Filament Tau | |
| P478 | volume | 270 |
| Q22254233 | 14-3-3zeta is an effector of tau protein phosphorylation |
| Q48395303 | A Simple Method to Avoid Nonspecific Signal When Using Monoclonal Anti-Tau Antibodies in Western Blotting of Mouse Brain Proteins |
| Q33808422 | A mutation affecting the sodium/proton exchanger, SLC9A6, causes mental retardation with tau deposition |
| Q33222589 | A single pair of acidic residues in the kinase major groove mediates strong substrate preference for P-2 or P-5 arginine in the AGC, CAMK, and STE kinase families |
| Q90597077 | A tau homeostasis signature is linked with the cellular and regional vulnerability of excitatory neurons to tau pathology |
| Q30487256 | A zebrafish model of tauopathy allows in vivo imaging of neuronal cell death and drug evaluation |
| Q54622561 | AMP-activated protein kinase (AMPK) is a tau kinase, activated in response to amyloid β-peptide exposure. |
| Q36941624 | AMP-activated protein kinase modulates tau phosphorylation and tau pathology in vivo |
| Q28215096 | Aberrant glycosylation modulates phosphorylation of tau by protein kinase A and dephosphorylation of tau by protein phosphatase 2A and 5 |
| Q44205872 | Abundant tau filaments and nonapoptotic neurodegeneration in transgenic mice expressing human P301S tau protein. |
| Q40796484 | Accumulation of vesicle-associated human tau in distal dendrites drives degeneration and tau secretion in an in situ cellular tauopathy model |
| Q35776950 | Acetylated tau, a novel pathological signature in Alzheimer's disease and other tauopathies |
| Q33652882 | Activated actin-depolymerizing factor/cofilin sequesters phosphorylated microtubule-associated protein during the assembly of alzheimer-like neuritic cytoskeletal striations. |
| Q36929023 | Activation of asparaginyl endopeptidase leads to Tau hyperphosphorylation in Alzheimer disease |
| Q43724620 | Activation of mitogen-activated protein kinase cascade and phosphorylation of cytoskeletal proteins after neurone-specific activation of p21ras. II. Cytoskeletal proteins and dendritic morphology |
| Q54965151 | Age-Dependent Emergence and Progression of a Tauopathy in Transgenic Mice Overexpressing the Shortest Human Tau Isoform |
| Q37073804 | Aging analysis reveals slowed tau turnover and enhanced stress response in a mouse model of tauopathy |
| Q34142269 | Alzheimer's disease as a disorder of mechanisms underlying structural brain self-organization |
| Q30478477 | Alzheimer's disease-like tau neuropathology leads to memory deficits and loss of functional synapses in a novel mutated tau transgenic mouse without any motor deficits |
| Q48553846 | Alzheimer-like changes in microtubule-associated protein Tau induced by sulfated glycosaminoglycans. Inhibition of microtubule binding, stimulation of phosphorylation, and filament assembly depend on the degree of sulfation |
| Q37029878 | Anesthesia-induced hyperphosphorylation detaches 3-repeat tau from microtubules without affecting their stability in vivo |
| Q47712655 | Apolipoprotein E and Tau phosphorylation in human neuroblastoma cells |
| Q46093982 | Argyrophilic grain disease: An underestimated tauopathy |
| Q28591578 | Attenuated neurodegenerative disease phenotype in tau transgenic mouse lacking neurofilaments |
| Q52566523 | Axonal degeneration induced by targeted expression of mutant human tau in oligodendrocytes of transgenic mice that model glial tauopathies. |
| Q36465091 | Biochemical classification of tauopathies by immunoblot, protein sequence and mass spectrometric analyses of sarkosyl-insoluble and trypsin-resistant tau |
| Q38023859 | Biochemistry and cell biology of tau protein in neurofibrillary degeneration |
| Q44282764 | Blockade of HMG-CoA reductase activity causes changes in microtubule-stabilizing protein tau via suppression of geranylgeranylpyrophosphate formation: implications for Alzheimer's disease |
| Q71171772 | Calcium/calmodulin-dependent protein kinase II phosphorylates tau at Ser-262 but only partially inhibits its binding to microtubules |
| Q48330860 | Caloric restriction mimetic 2-deoxyglucose maintains cytoarchitecture and reduces tau phosphorylation in primary culture of mouse hippocampal pyramidal neurons |
| Q49012146 | Characterization of mAb AP422, a novel phosphorylation-dependent monoclonal antibody against tau protein |
| Q34800214 | Combinatorial Tau pseudophosphorylation: markedly different regulatory effects on microtubule assembly and dynamic instability than the sum of the individual parts |
| Q48806762 | Combined Fmoc-Alloc strategy for a general SPPS of phosphoserine peptides; preparation of phosphorylation-dependent tau antisera. |
| Q28145739 | Comparative biochemistry of tau in progressive supranuclear palsy, corticobasal degeneration, FTDP-17 and Pick's disease |
| Q44555436 | Comparative distribution of tau phosphorylated at Ser262 in pre-tangles and tangles |
| Q53761895 | Conformation of paired helical filaments blocks dephosphorylation of epitopes shared with fetal tau except Ser199/202 and Ser202/Thr205. |
| Q34283467 | Cytoplasmic retention of protein phosphatase 2A inhibitor 2 (I2PP2A) induces Alzheimer-like abnormal hyperphosphorylation of Tau. |
| Q35227449 | DAPK activates MARK1/2 to regulate microtubule assembly, neuronal differentiation, and tau toxicity |
| Q36586085 | Deep clinical and neuropathological phenotyping of Pick disease |
| Q40261652 | Deletion of the ubiquitin ligase CHIP leads to the accumulation, but not the aggregation, of both endogenous phospho- and caspase-3-cleaved tau species. |
| Q28276894 | Dendritic changes in Alzheimer's disease and factors that may underlie these changes |
| Q48462144 | Developmental regulation and PKC dependence of Alzheimer's-type tau phosphorylations in cultured fetal rat hippocampal neurons |
| Q27307725 | Dexmedetomidine increases tau phosphorylation under normothermic conditions in vivo and in vitro |
| Q40794695 | Dishevelled regulates the metabolism of amyloid precursor protein via protein kinase C/mitogen-activated protein kinase and c-Jun terminal kinase. |
| Q34780780 | Distinct FTDP-17 missense mutations in tau produce tau aggregates and other pathological phenotypes in transfected CHO cells |
| Q24306132 | Doublecortin microtubule affinity is regulated by a balance of kinase and phosphatase activity at the leading edge of migrating neurons |
| Q48181237 | Dynamic regulation of expression and phosphorylation of tau by fibroblast growth factor-2 in neural progenitor cells from adult rat hippocampus |
| Q28578526 | Early growth response 1 (Egr-1) regulates phosphorylation of microtubule-associated protein tau in mammalian brain |
| Q43838097 | Ectopic white matter neurons, a developmental abnormality that may be caused by the PSEN1 S169L mutation in a case of familial AD with myoclonus and seizures |
| Q36694069 | Effect of acetylcholine on tau phosphorylation in human neuroblastoma cells |
| Q48158450 | Elevated neuronal Cdc2-like kinase activity in the Alzheimer disease brain. |
| Q24684804 | Familial multiple system tauopathy with presenile dementia: a disease with abundant neuronal and glial tau filaments |
| Q44068404 | First tau repeat domain binding to growing and taxol-stabilized microtubules, and serine 262 residue phosphorylation |
| Q35565682 | Functional genomic screen and network analysis reveal novel modifiers of tauopathy dissociated from tau phosphorylation |
| Q35001040 | GSK-3 in Neurodegenerative Diseases. |
| Q43867592 | Glycogen synthase kinase-3beta is complexed with tau protein in brain microtubules |
| Q53237934 | Glycogen synthase kinase-3beta phosphorylates protein tau and rescues the axonopathy in the central nervous system of human four-repeat tau transgenic mice. |
| Q42689688 | Haloperidol inactivates AMPK and reduces tau phosphorylation in a tau mouse model of Alzheimer's disease |
| Q40967467 | Heparin-induced conformational change in microtubule-associated protein Tau as detected by chemical cross-linking and phosphopeptide mapping |
| Q24315060 | Histone deacetylase 6 interacts with the microtubule-associated protein tau |
| Q43732934 | Hyperosmotic stress-induced apoptosis and tau phosphorylation in human neuroblastoma cells |
| Q40942539 | Hyperphosphorylated tau in SY5Y cells: similarities and dissimilarities to abnormally hyperphosphorylated tau from Alzheimer disease brain |
| Q45115027 | Hyperphosphorylation and aggregation of tau in experimental autoimmune encephalomyelitis |
| Q28566668 | I1PP2A affects tau phosphorylation via association with the catalytic subunit of protein phosphatase 2A |
| Q41494275 | Impaired neurogenesis is an early event in the etiology of familial Alzheimer's disease in transgenic mice |
| Q33568650 | Impairments in fast axonal transport and motor neuron deficits in transgenic mice expressing familial Alzheimer's disease-linked mutant presenilin 1 |
| Q43910654 | In vivo activation and nuclear translocation of phosphorylated glycogen synthase kinase-3beta in neuronal apoptosis: links to tau phosphorylation. |
| Q35065979 | Induction of intracellular tau aggregation is promoted by α-synuclein seeds and provides novel insights into the hyperphosphorylation of tau. |
| Q31924301 | Inhibition of PP-2A upregulates CaMKII in rat forebrain and induces hyperphosphorylation of tau at Ser 262/356. |
| Q48317438 | Inhibition of protein phosphatase 2A- and protein phosphatase 1-induced tau hyperphosphorylation and impairment of spatial memory retention in rats |
| Q36583411 | Intranasal Insulin Prevents Anesthesia-Induced Spatial Learning and Memory Deficit in Mice |
| Q38263698 | Invited review: Drug development for tauopathies |
| Q45099456 | Linking alterations in tau phosphorylation and cleavage during neuronal apoptosis. |
| Q48658321 | Lithium inhibits Alzheimer's disease-like tau protein phosphorylation in neurons |
| Q48589510 | Low initial tau phosphorylation in human brain biopsy samples |
| Q36756446 | Luteinizing hormone receptor activation in ovarian granulosa cells promotes protein kinase A-dependent dephosphorylation of microtubule-associated protein 2D. |
| Q34938739 | Lysine methylation is an endogenous post-translational modification of tau protein in human brain and a modulator of aggregation propensity. |
| Q55068033 | MAPs, MARKs and microtubule dynamics. |
| Q24313701 | MARK, a novel family of protein kinases that phosphorylate microtubule-associated proteins and trigger microtubule disruption |
| Q24299072 | MARK4 is a novel microtubule-associated proteins/microtubule affinity-regulating kinase that binds to the cellular microtubule network and to centrosomes |
| Q28551718 | Memantine Attenuates Alzheimer's Disease-Like Pathology and Cognitive Impairment |
| Q58485351 | Microtubule-Affinity Regulating Kinase (MARK) Is Tightly Associated with Neurofibrillary Tangles in Alzheimer Brain: A Fluorescence Resonance Energy Transfer Study |
| Q38713424 | Microtubule-Tau Interaction as a Therapeutic Target for Alzheimer's Disease |
| Q34610487 | Microtubule-associated protein tau as a therapeutic target in neurodegenerative disease |
| Q39812722 | Microtubule-associated protein tau in human prostate cancer cells: isoforms, phosphorylation, and interactions. |
| Q28374484 | Microtubule/MAP-affinity regulating kinase (MARK) is activated by phenylarsine oxide in situ and phosphorylates tau within its microtubule-binding domain |
| Q41809018 | Modulation of tau phosphorylation and intracellular localization by cellular stress |
| Q35567826 | Neural crest specification by noncanonical Wnt signaling and PAR-1 |
| Q37122158 | Neurochemical approaches of cerebrospinal fluid diagnostics in neurodegenerative diseases. |
| Q48291136 | Neurofibrillary pathology of Alzheimer's disease and other tauopathies. |
| Q49077012 | Neuropathology of Pick body disease |
| Q34156138 | New insights into genetic and molecular mechanisms of brain degeneration in tauopathies |
| Q41379250 | Normal and pathological Tau proteins as factors for microtubule assembly. |
| Q35791980 | Okadaic-acid-induced inhibition of protein phosphatase 2A produces activation of mitogen-activated protein kinases ERK1/2, MEK1/2, and p70 S6, similar to that in Alzheimer's disease |
| Q28537815 | Overexpression of 14-3-3z promotes tau phosphorylation at Ser262 and accelerates proteosomal degradation of synaptophysin in rat primary hippocampal neurons |
| Q47987669 | PAR-1 kinase plays an initiator role in a temporally ordered phosphorylation process that confers tau toxicity in Drosophila |
| Q36797362 | Paired helical filament tau (PHFtau) in Niemann-Pick type C disease is similar to PHFtau in Alzheimer's disease |
| Q24311461 | Parkinsonian neurotoxin 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) and alpha-synuclein mutations promote Tau protein phosphorylation at Ser262 and destabilize microtubule cytoskeleton in vitro |
| Q33603029 | Peptide conjugates as tools for the study of biological signal transduction |
| Q24292882 | Phosphorylation of microtubule-associated protein tau by AMPK-related kinases |
| Q44237402 | Phosphorylation of microtubule-associated protein tau by Ca2+/calmodulin-dependent protein kinase II in its tubulin binding sites |
| Q28242035 | Phosphorylation of microtubule-associated protein tau by stress-activated protein kinases |
| Q48595594 | Phosphorylation of microtubule-associated protein tau on Ser 262 by an embryonic 100 kDa protein kinase |
| Q28278995 | Phosphorylation of microtubule-associated proteins MAP2 and MAP4 by the protein kinase p110mark. Phosphorylation sites and regulation of microtubule dynamics |
| Q53224188 | Phosphorylation of specific sets of tau isoforms reflects different neurofibrillary degeneration processes. |
| Q60603639 | Phosphorylation of tau protein by recombinant GSK-3beta: pronounced phosphorylation at select Ser/Thr-Pro motifs but no phosphorylation at Ser262 in the repeat domain |
| Q48744508 | Pick's disease associated with the novel Tau gene mutation K369I. |
| Q48245898 | Postmortem changes in the phosphorylation state of tau-protein in the rat brain |
| Q44003364 | Progressive reduction of synaptophysin message in single neurons in Alzheimer disease |
| Q77296589 | Progressive supranuclear palsy |
| Q59812522 | Prolyl Isomerase Pin1 Directly Regulates Calcium/Calmodulin-Dependent Protein Kinase II Activity in Mouse Brains |
| Q36873750 | Prostate-derived sterile 20-like kinases (PSKs/TAOKs) phosphorylate tau protein and are activated in tangle-bearing neurons in Alzheimer disease |
| Q30502900 | Proteasome inhibition drives HDAC6-dependent recruitment of tau to aggresomes |
| Q48790449 | Protein kinase C and calcium/calmodulin-dependent protein kinase II phosphorylate three-repeat and four-repeat tau isoforms at different rates |
| Q24317775 | Protein kinase MARK/PAR-1 is required for neurite outgrowth and establishment of neuronal polarity |
| Q31111749 | Pseudophosphorylation and glycation of tau protein enhance but do not trigger fibrillization in vitro |
| Q57897037 | Rapid Tau Protein Dephosphorylation and Differential Rephosphorylation during Cardiac Arrest-Induced Cerebral Ischemia and Reperfusion |
| Q28478846 | Rapid changes in phospho-MAP/tau epitopes during neuronal stress: cofilin-actin rods primarily recruit microtubule binding domain epitopes |
| Q44662064 | Reduction of detyrosinated microtubules and Golgi fragmentation are linked to tau-induced degeneration in astrocytes. |
| Q24530141 | Regulated phosphorylation and dephosphorylation of tau protein: effects on microtubule interaction, intracellular trafficking and neurodegeneration |
| Q48137469 | Regulation of expression, phosphorylation and biological activity of tau during differentiation in SY5Y cells |
| Q35191074 | Regulation of phosphorylation of tau by cyclin-dependent kinase 5 and glycogen synthase kinase-3 at substrate level |
| Q45711453 | Role of glycosylation in hyperphosphorylation of tau in Alzheimer's disease |
| Q52162599 | Role of protein phosphatase-2A and -1 in the regulation of GSK-3, cdk5 and cdc2 and the phosphorylation of tau in rat forebrain. |
| Q44838137 | Role of tau phosphorylation by glycogen synthase kinase-3beta in the regulation of organelle transport |
| Q33612053 | Sequence Polymorphism and Intrinsic Structural Disorder as Related to Pathobiological Performance of the Helicobacter pylori CagA Oncoprotein |
| Q48360366 | Ser-262 in human recombinant tau protein is a markedly more favorable site for phosphorylation by CaMKII than PKA or PhK. |
| Q51803056 | Signaling from MARK to tau: regulation, cytoskeletal crosstalk, and pathological phosphorylation. |
| Q35747931 | Signature tau neuropathology in gray and white matter of corticobasal degeneration |
| Q92168050 | Site-Specific Hyperphosphorylation Inhibits, Rather than Promotes, Tau Fibrillization, Seeding Capacity, and Its Microtubule Binding |
| Q40281556 | Site-specific phosphorylation and caspase cleavage differentially impact tau-microtubule interactions and tau aggregation |
| Q45284384 | Site-specific pseudophosphorylation modulates the rate of tau filament dissociation |
| Q34913399 | Spatial learning impairment, enhanced CDK5/p35 activity, and downregulation of NMDA receptor expression in transgenic mice expressing tau-tubulin kinase 1. |
| Q43798231 | Spinal cord neurofibrillary pathology in Alzheimer disease and Guam Parkinsonism-dementia complex |
| Q59065184 | Structures of filaments from Pick's disease reveal a novel tau protein fold |
| Q90028587 | Tau Phosphorylation and Aggregation in the Developing Human Brain |
| Q37238281 | Tau aggregation and toxicity in tauopathic neurodegenerative diseases |
| Q35748075 | Tau and alpha-synuclein pathology in amygdala of Parkinsonism-dementia complex patients of Guam |
| Q27027415 | Tau and tauopathies |
| Q58028348 | Tau and transgenic animal models |
| Q37297103 | Tau antagonizes end-binding protein tracking at microtubule ends through a phosphorylation-dependent mechanism. |
| Q24312948 | Tau cleavage and dephosphorylation in cerebellar granule neurons undergoing apoptosis |
| Q38442790 | Tau gene mutation K257T causes a tauopathy similar to Pick's disease |
| Q42049071 | Tau pathology in two Dutch families with mutations in the microtubule-binding region of tau |
| Q43264384 | Tau phosphorylation at Alzheimer's disease-related Ser356 contributes to tau stabilization when PAR-1/MARK activity is elevated |
| Q30962853 | Tau protein is hyperphosphorylated in a site-specific manner in apoptotic neuronal PC12 cells |
| Q42059767 | Tau protein is phosphorylated by cyclic AMP-dependent protein kinase and calcium/calmodulin-dependent protein kinase II within its microtubule-binding domains at Ser-262 and Ser-356. |
| Q57897029 | Tau protein isoforms, phosphorylation and role in neurodegenerative disorders11These authors contributed equally to this work |
| Q48368290 | Tau protein pathology in neurodegenerative diseases |
| Q48650483 | Tau-targeting passive immunization modulates aspects of pathology in tau transgenic mice |
| Q38610025 | The development of cell processes induced by tau protein requires phosphorylation of serine 262 and 356 in the repeat domain and is inhibited by phosphorylation in the proline-rich domains |
| Q38611694 | The endogenous and cell cycle-dependent phosphorylation of tau protein in living cells: implications for Alzheimer's disease |
| Q57972071 | The function of the microtubule-associated protein tau is variably modulated by graded changes in glycogen synthase kinase-3β activity |
| Q47836536 | The interrelationship between selective tau phosphorylation and microtubule association |
| Q48957769 | The new indirubin derivative inhibitors of glycogen synthase kinase-3, 6-BIDECO and 6-BIMYEO, prevent tau phosphorylation and apoptosis induced by the inhibition of protein phosphatase-2A by okadaic acid in cultured neurons |
| Q46804886 | The potential for beta-structure in the repeat domain of tau protein determines aggregation, synaptic decay, neuronal loss, and coassembly with endogenous Tau in inducible mouse models of tauopathy. |
| Q48464116 | The regulation of phosphorylation of tau in SY5Y neuroblastoma cells: the role of protein phosphatases |
| Q34777685 | The role of tau in Alzheimer's disease |
| Q34138413 | The role of tau kinases in Alzheimer's disease |
| Q48691074 | The role of the VQIVYK peptide in tau protein phosphorylation |
| Q38734115 | The use of human neurons for novel drug discovery in dementia research. |
| Q24563378 | Therapeutic benefits of a component of coffee in a rat model of Alzheimer's disease |
| Q35754598 | Transgenic expression of the shortest human tau affects its compartmentalization and its phosphorylation as in the pretangle stage of Alzheimer's disease |
| Q44092251 | Transgenic mouse model of tauopathies with glial pathology and nervous system degeneration |
| Q35083891 | Up-regulation of inhibitors of protein phosphatase-2A in Alzheimer's disease |
| Q47163825 | What is the evidence that tau pathology spreads through prion-like propagation? |
| Q52667625 | gamma-cleavage-independent functions of presenilin, nicastrin, and Aph-1 regulate cell-junction organization and prevent tau toxicity in vivo. |
| Q35836408 | tau kinases in the rat heat shock model: possible implications for Alzheimer disease |
Search more.